STAT+: Why this startup is taking its AI to predict breast cancer risk directly to patients
Reported by STAT News · all stories from statnews.com
Editorial digest
This article explores why a new company decided to deliver its artificial intelligence tool for predicting breast cancer risk directly to patients. The approach bypasses traditional clinical pathways.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom10/14/2026
How consumer tech company Whoop is building for Medicare patients
A consumer technology firm is developing products for older adults on Medicare.
- Trusted health newsroom9/3/2026
STAT+: OpenEvidence launches new family of AI models
OpenEvidence introduces a new suite of AI models.
- Trusted health newsroom8/26/2026
STAT+: When it comes to women’s health, money talks
Funding is increasing for innovations in women's health.
- Trusted health newsroom8/26/2026
STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials
Daphne Koller from Insitro discusses using artificial intelligence to accelerate clinical studies.
- Trusted health newsroom8/12/2026
Assort Health rolls out AI agent to automate referrals for specialty practices and health systems - Fierce Healthcare
Assort Health introduces an AI agent to streamline patient referrals for specialty and health systems.
- Trusted health newsroom7/27/2026
Flourish Health secures $26M to scale intensive youth mental healthcare - Fierce Healthcare
Flourish Health raised $26 million to expand youth mental healthcare.